Serum interleukin-17 and estradiol levels in postmenopausal women in relation to osteoporosis

Egyptian Rheumatology and Rehabilitation

Table 3 Comparative statistics between the 2 groups regarding laboratory data

Investigations		Non-osteoporotic group	Osteoporotic group	Test value	P value	Sig.
Investigations		No. = 30	No. = 30	Test value	P value	Sig.
ESR	Mean ± SD	10.71 ± 3.14	9.66 ± 2.55	1.002•	0.325	NS
ESR	Range	5.2-14.6	5.7-14	1.002•	0.325	NS
CRP	Mean ± SD	1.97 ± 0.65	1.90 ± 0.72	0.294•	0.771	NS
CRP	Range	1-2.9	1-2.9	0.294•	0.771	NS
PTH	Mean ± SD	43.77 ± 14.27	40.60 ± 15.85	0.576•	0.569	NS
PTH	Range	17.9-64.1	13.4-63.9	0.576•	0.569	NS
Estradiol (E2)	Median (IQR)	240 (150-300)	20 (5-25)	4.635^≠	0.000	HS
Estradiol (E2)	Range	75-500	4-100	4.635^≠	0.000	HS
IL-17	Median (IQR)	60 (50-60)	280 (240-300)	4.696^≠	0.000	HS
IL-17	Range	45-80	160-480	4.696^≠	0.000	HS

P value ≤ 0.05, non-significant; P value ≤ 0.05, significant; P value ≤ 0.01, highly significant
•Independent t test
^≠Mann-Whitney test
ESR erythrocyte sedimentation rate, CRP C-reactive protein, PTH parathyroid hormone, IL-17 interleukin-17